Pro Medicus initiated with an Overweight at Morgan Stanley

Morgan Stanley initiated coverage of Pro Medicus (PMCUF) with an Overweight rating and A$300 price target PME Visage 7 software “creates significant value for its customers, underpinning our confidence on future contract opportunities,” says the analyst, who notes that the firm’s survey of 99 U.S. hospital executives found over 55% of respondents are likely to deploy Visage 7 over the next 12 months.